AbbVie Sets a $1.73 Quarterly Dividend for November 16

AbbVie's board declared a quarterly cash dividend of $1.73 per share, payable November 16, 2026, to stockholders of record at the close of business on October 15, 2026.

AbbVie's board of directors has declared a quarterly cash dividend of $1.73 per share, keeping intact a payout record the drugmaker has built since it was spun out as a standalone company in 2013. The dividend is payable on November 16, 2026, to stockholders of record at the close of business on October 15, 2026.

The declaration was one of five reported in Friday's dividend round-up from Nasdaq Markets, alongside Meta Platforms, W. R. Berkley, Granite Construction and Applied Materials. AbbVie (ABBV) traded at 257.59 as of the last trade at 17:39 GMT on Friday, September 11, up 1.02% on the day from a previous close of 255.00, with an intraday range of 253.92 to 259.61.

The two dates that decide who gets paid

For income investors, the calendar matters more than the headline rate. The record date — October 15, 2026, at the close of business — is the cutoff that determines eligibility. An investor must be a holder of record on that date to collect the November 16 payment. Because equity trades settle after the fact, buyers typically need to own the shares before the ex-dividend date, which falls just ahead of the record date; anyone selling after that point still receives the cash.

The gap between the two dates here is roughly a month, which is ordinary for a large-cap payer. It also means the November payment is already locked in from a planning standpoint: a shareholder deciding today whether to hold through October has a fixed, declared amount to weigh rather than an estimate.

A payout record that dates to the 2013 split

AbbVie has increased its dividend since the company's inception in 2013, when it separated from its former parent. That continuity is the single most important fact in the declaration. A long unbroken record of increases is what qualifies a stock for the dividend-growth screens that many retirement portfolios and income-focused exchange-traded funds use, and losing that status tends to trigger forced selling by funds built around it.

Maintaining the streak is not costless. A pharmaceutical company's cash flows are tied to patent lives, and a board that commits to a rising payout is committing to fund it through the periods when a major product loses exclusivity. Investors watching AbbVie's dividend should therefore treat each declaration less as news in itself and more as a signal about management's confidence in near-term cash generation.

A single quarterly rate can also be annualised for illustration. Four payments at the declared $1.73 rate would come to $6.92 per share over a year, assuming the rate were simply held flat — an arithmetic exercise, not a company forecast, since the board sets each quarter's dividend separately and has historically raised it. Against Friday's last trade of 257.59, that illustrative annual figure works out to roughly 2.7% of the share price.

Four more declarations, four very different businesses

The other names in Friday's round-up span sectors with little in common beyond the habit of returning cash. Meta Platforms (META) traded at 650.33, up 0.92% from a previous close of 644.38, with a day range of 647.40 to 664.24 — a comparatively recent entrant to the dividend-paying ranks among large technology companies, where buybacks have historically dominated.

W. R. Berkley (WRB) was the only decliner of the group, at 69.82, down 0.33% from 70.05 and trading between 69.58 and 70.98. Property-casualty insurers are structurally steady dividend payers because premium float generates investment income, though underwriting cycles and catastrophe losses can swing reported earnings sharply from quarter to quarter.

Granite Construction (GVA) was the strongest mover on the day, at 117.20, up 1.69% from a previous close of 115.25 after ranging from 115.94 to 120.10. Heavy civil construction is a cyclical, backlog-driven business, which makes a dividend commitment there a different proposition from a pharmaceutical or insurance payout.

Applied Materials (AMAT) traded at 461.82, up 1.72% from 454.01, with a range of 452.70 to 464.57. Semiconductor capital equipment is among the most cyclical corners of technology; the companies in it have generally treated dividends as a modest base layer of returns and buybacks as the flexible top layer.

A broadly higher tape behind the declarations

All four gainers moved with a firm market. The SPDR S&P 500 ETF (SPY) stood at $765.93, up 1.07% from a previous close of $757.83, inside a $763.60 to $766.38 range. The Invesco QQQ Trust (QQQ), tracking the Nasdaq 100, was at $716.82, up 1.15% from $708.69. The SPDR Dow Jones Industrial Average ETF (DIA) traded at $526.64, up 1.13% from $520.75.

That matters for reading the moves in the five stocks. AbbVie's 1.02% gain, Meta's 0.92% and Berkley's 0.33% decline were all within or below the broad market's advance, meaning none of the dividend declarations produced an obvious stock-specific reaction. Granite and Applied Materials, at 1.69% and 1.72%, edged ahead of the indices. Dividend declarations at companies with established payout policies rarely move shares much on their own; the information content is usually in a rate change, not the fact of a payment.

What income investors should watch from here

33% decline were all within or below the broad market's advance, meaning none of the dividend declarations produced an obvious stock-specific reaction.

Three things are worth tracking after a declaration like this one. The first is whether the rate itself changes at the next scheduled board decision — that is where the dividend-growth story either continues or stalls. The second is the relationship between the payout and free cash flow, because a rising dividend funded by shrinking coverage is a different animal from one funded by growing earnings.

The third is price. Yield moves inversely to the share price, so a stock that rallies hard delivers a lower forward yield on new money even as the payment to existing holders is unchanged. Anyone buying AbbVie for income on Friday at 257.59 is buying a lower yield than someone who bought at the day's low of 253.92 — a small difference on one trade, but a meaningful one compounded across a large position built over time.

For now the mechanics are settled: $1.73 per share, record October 15, paid November 16. The next question is what the board does with the rate.

Key facts

Dividend declared: $1.73 per share, quarterly
Payment and record dates: Payable Nov. 16, 2026; record Oct. 15, 2026
ABBV last trade: 257.59, +1.02% as of 17:39 GMT Sept. 11, 2026
Dividend record: Increased since AbbVie's 2013 inception

Frequently asked questions

How much is AbbVie's declared quarterly dividend?

AbbVie's board declared a quarterly cash dividend of $1.73 per share. The payment is scheduled for November 16, 2026, and goes to stockholders of record at the close of business on October 15, 2026. The declaration was reported in Nasdaq's daily dividend round-up on September 11, 2026.

When do I need to own the shares to receive the payment?

You must be a holder of record at the close of business on October 15, 2026. In practice that means buying before the ex-dividend date, which falls just ahead of the record date. If you sell after the record date, you still receive the November 16 payment.

How long has AbbVie been raising its dividend?

AbbVie has increased its dividend since the company's inception in 2013, when it became a standalone business. That unbroken record of increases is what qualifies the stock for many dividend-growth screens and income-focused funds, which is why boards work hard to preserve such streaks.

Where was AbbVie stock trading when the dividend was reported?

AbbVie traded at 257.59 as of the last trade at 17:39 GMT on Friday, September 11, 2026, up 1.02% from a previous close of 255.00. The intraday range was 253.92 to 259.61. The broad market was also higher, with the S&P 500 ETF up 1.07% on the day.

Which other companies declared dividends in the same report?

Four others were covered: Meta Platforms, W. R. Berkley, Granite Construction and Applied Materials. On the day, Meta traded at 650.33 (+0.92%), W. R. Berkley at 69.82 (-0.33%), Granite Construction at 117.20 (+1.69%) and Applied Materials at 461.82 (+1.72%).

Do dividend declarations usually move a stock's price?

Not much, when the company already has an established payout policy. The market typically prices in a routine quarterly declaration in advance. Share prices react more to a change in the rate — an increase, a cut or a suspension — than to the scheduled confirmation that a payment is being made.

Sources

Daily Dividend Report: ABBV,META,WRB,GVA,AMAT — Nasdaq Markets

Photo: https://kaboompics.com/ · Pexels Licence — source